Literature DB >> 19342189

Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders.

Susan J Astley1, Todd Richards, Elizabeth H Aylward, Heather Carmichael Olson, Kimberly Kerns, Allison Brooks, Truman E Coggins, Julian Davies, Susan Dorn, Beth Gendler, Tracy Jirikowic, Paul Kraegel, Kenneth Maravilla.   

Abstract

Magnetic resonance (MR) technology offers noninvasive methods for in vivo assessment of neuroabnormalities. A comprehensive neuropsychological/behavioral, MR imaging (MRI), MR spectroscopy (MRS) and functional MRI (fMRI) assessment was administered to children with fetal alcohol spectrum disorders (FASD) to determine whether global and/or focal abnormalities could be identified and to distinguish diagnostic subclassifications across the spectrum. The four study groups included (1) FAS/partial FAS; (2) static encephalopathy/alcohol exposed (SE/AE); (3) neurobehavioral disorder/alcohol exposed (ND/AE) as diagnosed with the FASD 4-Digit Code; and (4) healthy peers with no prenatal alcohol exposure. Results are presented in four separate reports: MRS (reported here) and neuropsychological/behavioral, MRI and fMRI outcomes (reported separately). MRS was used to compare neurometabolite concentrations [choline (Cho), n-acetyl-aspartate (NAA) and creatine (Cre)] in a white matter region and a hippocampal region between the four study groups. Choline concentration in the frontal/parietal white matter region, lateral to the midsection of the corpus callosum, was significantly lower in FAS/PFAS relative to all other study groups. Choline decreased significantly with decreasing frontal white matter volume and corpus callosum length. These outcomes suggest low choline concentrations may reflect white matter deficits among FAS/PFAS. Choline also decreased significantly with increasing severity of the 4-Digit FAS facial phenotype, increasing impairment in psychological performance and increasing alcohol exposure. NAA and Cre concentrations did not vary significantly. This study provides further evidence of the vulnerability of the cholinergic system in FASD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342189      PMCID: PMC4230827          DOI: 10.1016/j.mri.2009.01.003

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  68 in total

Review 1.  Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure.

Authors:  C Guerri
Journal:  Alcohol Clin Exp Res       Date:  1998-04       Impact factor: 3.455

2.  A case definition and photographic screening tool for the facial phenotype of fetal alcohol syndrome.

Authors:  S J Astley; S K Clarren
Journal:  J Pediatr       Date:  1996-07       Impact factor: 4.406

3.  Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.

Authors:  D Wiedermann; N Schuff; G B Matson; B J Soher; A T Du; A A Maudsley; M W Weiner
Journal:  Magn Reson Imaging       Date:  2001-10       Impact factor: 2.546

Review 4.  Defining the behavioral phenotype in children with fetal alcohol spectrum disorders: a review.

Authors:  P W Kodituwakku
Journal:  Neurosci Biobehav Rev       Date:  2006-08-23       Impact factor: 8.989

5.  Brain perfusion SPECT and MRI in foetal alcohol syndrome.

Authors:  R Riikonen; I Salonen; K Partanen; S Verho
Journal:  Dev Med Child Neurol       Date:  1999-10       Impact factor: 5.449

6.  Magnetic resonance imaging and spectroscopy in fetal ethanol exposed Macaca nemestrina.

Authors:  S J Astley; E Weinberger; D W Shaw; T L Richards; S K Clarren
Journal:  Neurotoxicol Teratol       Date:  1995 Sep-Oct       Impact factor: 3.763

7.  Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis.

Authors:  Albert E Chudley; Julianne Conry; Jocelynn L Cook; Christine Loock; Ted Rosales; Nicole LeBlanc
Journal:  CMAJ       Date:  2005-03-01       Impact factor: 8.262

8.  Reproducibility of 1H-MRS in vivo.

Authors:  W M Brooks; S D Friedman; C A Stidley
Journal:  Magn Reson Med       Date:  1999-01       Impact factor: 4.668

9.  Development of neurotransmitter systems in the mouse embryo following acute ethanol exposure: a histological and immunocytochemical study.

Authors:  U B Schambra; J M Lauder; P Petrusz; K K Sulik
Journal:  Int J Dev Neurosci       Date:  1990       Impact factor: 2.457

10.  Memory and cognitive function in man: does the cholinergic system have a specific role?

Authors:  D A Drachman
Journal:  Neurology       Date:  1977-08       Impact factor: 9.910

View more
  27 in total

1.  Persistent dose-dependent changes in brain structure in young adults with low-to-moderate alcohol exposure in utero.

Authors:  Kristen L Eckstrand; Zhaohua Ding; Neil C Dodge; Ronald L Cowan; Joseph L Jacobson; Sandra W Jacobson; Malcolm J Avison
Journal:  Alcohol Clin Exp Res       Date:  2012-05-17       Impact factor: 3.455

2.  Regional brain volume reductions relate to facial dysmorphology and neurocognitive function in fetal alcohol spectrum disorders.

Authors:  Florence F Roussotte; Kathleen K Sulik; Sarah N Mattson; Edward P Riley; Kenneth L Jones; Colleen M Adnams; Philip A May; Mary J O'Connor; Katherine L Narr; Elizabeth R Sowell
Journal:  Hum Brain Mapp       Date:  2011-03-17       Impact factor: 5.038

3.  Differential neuroimaging indices in prefrontal white matter in prenatal alcohol-associated ADHD versus idiopathic ADHD.

Authors:  Joseph O'Neill; Mary J O'Connor; Victor Yee; Ronald Ly; Katherine Narr; Jeffrey R Alger; Jennifer G Levitt
Journal:  Birth Defects Res       Date:  2019-01-29       Impact factor: 2.344

4.  MR spectroscopy of the fetal brain: is it possible without sedation?

Authors:  V Berger-Kulemann; P C Brugger; D Pugash; M Krssak; M Weber; A Wielandner; D Prayer
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

5.  Fetal alcohol spectrum disorders: gene-environment interactions, predictive biomarkers, and the relationship between structural alterations in the brain and functional outcomes.

Authors:  James N Reynolds; Joanne Weinberg; Sterling Clarren; Christian Beaulieu; Carmen Rasmussen; Michael Kobor; Marie-Pierre Dube; Daniel Goldowitz
Journal:  Semin Pediatr Neurol       Date:  2011-03       Impact factor: 1.636

Review 6.  Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder.

Authors:  Shonagh K O'Leary-Moore; Scott E Parnell; Robert J Lipinski; Kathleen K Sulik
Journal:  Neuropsychol Rev       Date:  2011-03-29       Impact factor: 7.444

Review 7.  Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging.

Authors:  Florence Roussotte; Lindsay Soderberg; Elizabeth Sowell
Journal:  Neuropsychol Rev       Date:  2010-10-28       Impact factor: 7.444

Review 8.  Fetal alcohol spectrum disorders.

Authors:  Nora Dörrie; Manuel Föcker; Inga Freunscht; Johannes Hebebrand
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-06-26       Impact factor: 4.785

9.  Cortical miscommunication after prenatal exposure to alcohol.

Authors:  Scott M Lewis; Rosa R Vydrová; Arthur C Leuthold; Apostolos P Georgopoulos
Journal:  Exp Brain Res       Date:  2016-08-04       Impact factor: 1.972

10.  Magnetic resonance imaging outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders.

Authors:  Susan J Astley; Elizabeth H Aylward; Heather Carmichael Olson; Kimberly Kerns; Allison Brooks; Truman E Coggins; Julian Davies; Susan Dorn; Beth Gendler; Tracy Jirikowic; Paul Kraegel; Kenneth Maravilla; Todd Richards
Journal:  Alcohol Clin Exp Res       Date:  2009-07-01       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.